Powered by Google
Bristol-Myers Squibb Company (NYSE: BMY) and the Gladstone Institutes today announced the formation of a discovery-based research collaboration to identify and validate novel targets in Alzheimer’s disease.
Saturday, May 18, 2013
Full calendar | Add to Outlook/iCal
Copyright © 2011 MedTech